Clinical Trials
7 trialsNCT03112603 2025-08-12
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Incyte Corporation
Phase 3 Completed
NCT00179855 2025-02-12
Extracorporeal Photopheresis for Acute Graft Versus Host Disease
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 2/3 Completed
NCT00045305 2023-06-28
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00179790 2017-03-06
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1/2 Completed
NCT00402714 2017-01-18
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
Yale University
Phase 2 Completed
NCT01174940 2017-01-09
Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT00306969 2006-03-27
Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
Boston University
Phase 1/2 Completed